Fred Alger Management, LLC Axonics, Inc. Transaction History

Fred Alger Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$47.99 - $60.21 $11.4 Million - $14.3 Million	-236,870 Reduced 28.48%	594,870 $30 Million
Q1 2023 May 15, 2023	SELL	$52.6 - $67.34 $4.83 Million - $6.19 Million	-91,868 Reduced 9.95%	831,740 $45.4 Million
Q4 2022 Feb 14, 2023	SELL	$59.56 - $76.6 $2.3 Million - $2.95 Million	-38,555 Reduced 4.01%	923,608 $57.8 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $55.8 Million - $75.2 Million	962,163 New	962,163 $67.8 Million

235

42.8M

73.7K

230K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.45B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.